Finance

Lists
ABL:ETR
Abbott Laboratories
€87.86
-0.79%
(-0.70) 1D
Jul 22, 5:35:45 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ABL...
Open
€87.66
High
€87.90
Low
€87.30
Mkt. cap
175.17B
Avg. vol.
1.34K
Volume
517.00
52-wk high
€116.56
52-wk low
€70.10
No. of employees
115K
Open
€87.66
High
€87.90
Low
€87.30
Mkt. cap
175.17B
Avg. vol.
1.34K
Volume
517.00
52-wk high
€116.56
52-wk low
€70.10
No. of employees
115K
News stories
From sources across the web
Profile
Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company founded in Chicago with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices. Abbott operates in over 160 countries and sources from at least 62 suppliers worldwide. Abbott's products include Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip. The company is ranked 107th on the Fortune 500 and 144th on the Forbes Global 2000. Wikipedia
About Abbott Laboratories
CEORobert B. Ford
Employees115K
Founded1888
HeadquartersChicago, Illinois, United States
SectorMedical device
Websiteabbott.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
11.37B
11.46B
11.16B
12.59B
Cost of goods sold
5.08B
4.91B
4.89B
5.29B
Cost of revenue
5.08B
4.91B
4.89B
5.29B
Research and development expenses
766.00M
720.00M
767.00M
882.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.90B
2.93B
3.58B
3.98B
Operating expense
4.09B
4.07B
4.77B
5.52B
Total operating expenses
9.16B
8.98B
9.66B
10.81B
Operating income
2.20B
2.48B
1.50B
1.78B
Other non operating income
2.00M
-15.00M
-
134.00M
EBT including unusual items
2.18B
2.36B
1.45B
1.52B
EBT excluding unusual items
2.18B
2.44B
1.45B
1.61B
Income tax expense
536.00M
582.00M
372.00M
596.00M
Effective tax rate
24.59%
24.68%
25.67%
39.11%
Other operating expenses
-
-
-
-
Net income
1.64B
1.78B
1.08B
928.00M
Net profit margin
14.46%
15.50%
9.65%
7.37%
Earnings per share
1.30
1.50
1.15
1.31
Interest and investment income
77.00M
78.00M
106.00M
-
Interest expense
-121.00M
-120.00M
-174.00M
-299.00M
Net interest expenses
-44.00M
-42.00M
-68.00M
-299.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
3.00B
3.27B
2.31B
2.58B
Gain or loss from assets sale
-
65.00M
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer